Lyne Breault

This inventor holds 1 USPTO granted patent. Top assignee: Aveo Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lyne Breault. Retrieved from https://idiyas.com/inventor/lyne-breault-t7lljeek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Lyne Breault

Introduction

Lyne Breault is a notable inventor recognized for her contributions to the field of biotechnology. She is currently associated with Aveo Pharmaceuticals, Inc., where she has made significant strides in her research and development efforts.

Latest Patents

Lyne Breault holds a patent for "ANTI-ERBB3 ANTIBODIES," showcasing her innovative approach to addressing critical health challenges. This patent represents her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout her career, Lyne has demonstrated exceptional expertise in her field. Her work at Aveo Pharmaceuticals, Inc. has positioned her as a key player in the development of novel therapeutic solutions.

Collaborations

Lyne has collaborated with esteemed colleagues, including Sylvie Vincent and William M Winston, Jr. These partnerships have further enhanced her research capabilities and contributed to the success of her projects.

Conclusion

Lyne Breault's innovative spirit and dedication to her work have made her a valuable asset in the biotechnology industry. Her contributions continue to pave the way for advancements in medical research and treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…